Most lately, it's been discovered that conolidine and the above mentioned derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in comparable regions as classical opioid receptors, it binds to your wide array of endogenous opioids. Compared with most opioid receptors, this receptor acts to be a scavenger https://thomasb316aqy3.azzablog.com/profile